title: [Novel immunosuppressive drugs in renal transplantation].
abstract: The major targets of novel immunosuppressive protocols are decreased toxicity and improved graft and patient survival. Over the last decade, several drugs have been demonstrated to have potential beneficial effect in transplantation. Most of these agents are currently in phase II or III of clinical studies.
authors.affiliation: Klinicki bolnicki centar Zagreb i Medicinski fakultet Sveucilista u Zagrebu, Zavod za nefrologiju, arterijsku hipertenziju i dijalizu, Zagreb, Hrvatska. nina_basic@net.hr
authors.forename: Nikolina
authors.initials: N
authors.lastname: Basić-Jukić
authors.forename: Petar
authors.initials: P
authors.lastname: Kes
mesh_terms: D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation
chemical_list: D007166:Immunosuppressive Agents